First thing that happens in case of
hemorrhage is vasoconstriction
Angiotensin
Endothelin
Hemostasis
Primary
Platelet interaction with subendothelial
structures and plaque formation
Secondary
Clotting: thrombin and subsequent fibrin generation
Primary hemostasis
Main subendothelial structures involved
Collagen
Von Willebrand factor
Synthesized by endothelium and
stored in Weibel-Palade bodies
Thrombotic Thrombocytopenic Purpura (TTP)
ADAMTS13 inhibits formation of very high mW forms of vWF
You need 2 main signals
Presence of Ca2+
Flow
Synthesized as a dimer with
many interactive domains:
A1 is the domain interacting with platelet receptor GpIb
A3 is the domain interacting with collagen
C1 is the domain interacting with IIbIIIa on activated platelets
Very high degree of polymerization
2 activities:
Activity in primary hemostasis to permit the
contact between platelets and the sub endothelium
Carrier of factor VIII within the circulation
Platelet granules
Delta granules
Contain ATP and ADP
ADP interacts with additional
receptors (P2Y1 and P2Y12)
Alpha granules
Platelet receptors
IIbIIIa receptor
It interacts with either vWF or fibrinogen
GpIb is the main receptor that is constitutively
expressed on the membrane of resting platelets
Receptor for vWF
First contact that platelets
make with the subendothelium
Glycoprotein VI
Constitutive receptor for collagen
Secondary hemostasis
Tissue factor
Main receptor for factor VII
Only factor VII bound to tissue factor is pro-coagulant
Phospholipids must be expressed on top of the cell
membrane and they are crucial for complex formation
Vitamin K-dependent clogging proteins
Factor II, VII, IX, X
When platelets get activated you have the so-called flip-flop mechanism so the negative
charges go towards the circulating blood and the positive charges are moved in
This contributes to the assembly of the clotting complex
The substrate of the factor VIIa+TF complex
is factor X that is activated to factor Xa
VIIa+TF also leads to factor IX activation (but factor X is preferred
just because its concentration is twice the concentration of factor IX)
Factor IX can also activate factor X on a phospholipid surface
Factor IX-VIII+X complex is called tenase
Prothrombinase
Composed by factor Xa, prothrombin and factor V
Factor V has to be proteolitically cleaved
by thrombin or Xa into an active form
Thrombin
Roles of thrombin
It promotes fibrin formation
In order for the fibrin to become insoluble the polymers
need to become cross-linked by the activity of factor XIIIa
It starts the fibrinolysis
It induces the release form the epithelium of tPA
this leads to activation of plasminogen to plasmin
Plasmin degrades fibrin into
small pieces called D-dimers
Inhibitors of tPA: Plasminogen activator inhibitor (PAI) 1 and 2
They also inhibit urokinase (another activator of plasminogen)
It promotes platelet aggregation
It promotes inhibition of fibrinolysis
By promoting the release of PAIs and via the action of procarboxypeptidase,
which is transformed in active carboxypeptidase by thrombin itself
It also promotes positive feedback on its own production
In fact it transforms factor V and factor VIII in their active
form as cofactors of tenase and prothrombinase complexes
It also has roles in inflammation
Anticoagulant properties (it creates aPC and it
induces prostacyclin release from the endothelium
It doesn't need the presence of a phospholipid surface to work
Three main natural anticoagulant systems
Tissue Factor Pathway Inhibitor
TFPI+glycosaminoglycans complex effectively
inhibits factor Xa and complexes with it
In turn this complex inhibits the complex of factor VIIa+tissue factor
Antithrombin Heparin System
It targets the enzymes of the clotting system
Protein C System
It targets factor VIIIa and factor Va
Protein C is a vitamin K
dependent protein
Activated protein C (aPC) forms a complex with another vitamin K-dependent protein, protein S,
and the protein C+S complex inactivates the activated forms of factor VIII and factor V by proteolysis
A very common mutation of factor V, called factor V
Leiden, renders factor V resistant to inactivation by aPC
They act on top of endothelial cells
(where they can be more effective)